On the recordJuly 20, 2010
One challenge that many of the witnesses today spoke of is the need to incentivize the device and drug/biotech industry to develop therapeutics for rare, pediatric diseases.
Source
congress.govOne challenge that many of the witnesses today spoke of is the need to incentivize the device and drug/biotech industry to develop therapeutics for rare, pediatric diseases.
Hagan emphasizes the need for incentives in developing treatments for rare pediatric diseases.
Share & report
More from Kay Hagan
We are also thankful to those on this committee who have been supportive of this bill, including Senator Casey of Pennsylvania and Senator Kay Hagan of North Carolina.
If we want to influence the workforce 15 to 20 years from now, we really need to have that outreach in our K through 12 programs.
I would like to see what steps we can take to strengthen the tie between DOD and HBCUs.